Jitendra Patel – författare

It is the goal of The Metabotropic Glutamate Receptors to provide acomprehensive and forward-thinking review ofthe tremen- dous advances that have occurred in less than a decade of metabotropic glutamate receptors (mGluR) research. Virtually every areaof mGluR research is covered, including the molecular biology, pharmacology, anatomical distribution, and physiological and pathological roles of mGluRs. It is our intention that this volume not only summarize what is now known about the mGluRs, but also illuminate the areas in which there is the greatest need for focused research. Glutamic acid is an amino acid that has long been known to play several important metabolic roles in central and peripheral tissues and to be a component of several naturally occurring molecules. The first evidence that glutamate mayaIso serve as a neurotransmitter in the central nervous system (CNS) came in the late 1950s and early 1960s when glutamate and other acidic amino acids were found to induce behavioral convulsions when topically applied to the cortex and to excite a wide variety of central neurons.These findings spurred a massive research effort that quickly established glutamate as the pri- mary excitatory neurotransmitter in the vertebrate CNS. One of the most striking characteristics of glutamate that was quickly recognized was its ubiquitous role in serving as the neurotransmitter at the vast majority of excitatory synapses in the brain. It is now clear that most central neuronal circuits involve glutamatergic neurotransmission at some level.

In Neurotherapeutics: Emerging Strategies neuroscientists, clinicians, and industry-based pharmacologists and chemists review emerging approaches for the treatment of diseases of the central nervous system. The contributors - all key investigators of novel therapeutics - focus on developing rational strategies for drug design based on the new understanding of the underlying pathophysiology of central nervous system diseases. In the process, the contributors review the efficacy and mechanisms of current treatments as well as the latest research results and their potential therapeutic impact. Common to all chapters is the promise held out by newly cloned receptor subtypes of therapeutics with improved selectivity and potency. Also explored is the potential for novel therapeutics from a developing understanding of signal transduction. The diseases discussed range from affective disorders and Alzheimer's disease to Parkinson's disease and schizophrenia, as well as anxiety, panic disorders, stroke, epilepsy, and Huntington's disease.

Core Java Programming : This book is specially written for beginner Java Students and Programmers to gain fundamentals knowledge about Java programming using easy to use practice examples. This book contains a track for those who are afraid of Java Programming and are confused about how to start Java? Which way to start? Also every one with interest in Java Programming can refer this book to get the knowledge about Various features the subject.It covers virtually most of Java and JVM features and some of the advanced features like AWT, Swing, Multithreading, Applets etc... including more than hands on examples tested. Samples are presented in easy to use way through Java Language.

PHP & MySQL Practice It Learn It: This manual teaches the Programming stuffs in using PHP programming language in an easy-to-follow style. A variety of examples make learning these Concepts with PHP both fun and practical. This manual is organized in such a manner that students and programmers with basic prior knowledge of Programming can find it easy, crisp and readable. Each Chapter contains many example programs throughout the book, along with additional examples for further practice.KEY FEATURESSystematic approach throughout the bookProgramming basics in PHP without requiring previous experience in another languageSimple language has been adopted to make the topics easy and clear to the readersTopics have been covered with numerous illustrations and tested PHP programsEnough examples have been used to explain various Programming Constructs effectively. This book also consists of tested programs so as to enable the readers to learn the logic of programmingDiscusses all generic concepts of Computer Programming concepts such as Conditional and Looping Structures and Array in detail with aided examplesUse of Various Programming terms like variables and expressions, functions are simplifiedA number of diagrams have been provided to clear the concepts in more illustrative waySamples are presented in easy to use way through Wamp.

Neuroscience's inherent complexity and rapid growth mean that no one can keep abreast of all the changes across the field. We each bring a necessarily narrow perspective. Neurotherapeutics: Emerg­ ing Strategies is an attempt to provide some diverse perspectives within the hunt for new drugs to treat central nervous system diseases. The book's premise is that the search for new drugs is based on an understanding ofboth clinical and basic sciences. Neurotherapeu­ tics: Emerging Strategies begins with psychiatry and concludes with neurological disorders. Each chapter examines a disease, including clinical features and existing treatments, but the emphasis is on current concepts of underlying causes and novel strategies for drug discovery arising from these possible mechanisms. Participating authors include basic neuroscientists, industry-based pharmacolo­ gists and chemists, and clinicians. The chapters describe the status of the existing disease treat­ ments, and when treatments are lacking, the approach is more basic science oriented. When there is a long history of treatment, there is greater emphasis on those therapies. However, all the chapters seem to reflect the benefits of cloning, since the availability of receptor subtypes now promises the opportunity for greater specificity of drug effects. Modulation of second messengers is another new and recur­ ring theme. And in the chapter on cachexia, cytokines are explored both as drugs and drug targets. Neurotherapeutics: Emerging Strategies reflects the complex­ ity of the nervous system, but the overriding message is hope for new and better drugs to treat those diseases that rob us of ourselves.

Neuroscience''s inherent complexity and rapid growth mean that no one can keep abreast of all the changes across the field. We each bring a necessarily narrow perspective. Neurotherapeutics: Emerg­ ing Strategies is an attempt to provide some diverse perspectives within the hunt for new drugs to treat central nervous system diseases. The book''s premise is that the search for new drugs is based on an understanding ofboth clinical and basic sciences. Neurotherapeu­ tics: Emerging Strategies begins with psychiatry and concludes with neurological disorders. Each chapter examines a disease, including clinical features and existing treatments, but the emphasis is on current concepts of underlying causes and novel strategies for drug discovery arising from these possible mechanisms. Participating authors include basic neuroscientists, industry-based pharmacolo­ gists and chemists, and clinicians. The chapters describe the status of the existing disease treat­ ments, and when treatments are lacking, the approach is more basic science oriented. When there is a long history of treatment, there is greater emphasis on those therapies. However, all the chapters seem to reflect the benefits of cloning, since the availability of receptor subtypes now promises the opportunity for greater specificity of drug effects. Modulation of second messengers is another new and recur­ ring theme. And in the chapter on cachexia, cytokines are explored both as drugs and drug targets. Neurotherapeutics: Emerging Strategies reflects the complex­ ity of the nervous system, but the overriding message is hope for new and better drugs to treat those diseases that rob us of ourselves.

It is the goal of The Metabotropic Glutamate Receptors to provide acomprehensive and forward-thinking review ofthe tremen- dous advances that have occurred in less than a decade of metabotropic glutamate receptors (mGluR) research. Virtually every areaof mGluR research is covered, including the molecular biology, pharmacology, anatomical distribution, and physiological and pathological roles of mGluRs. It is our intention that this volume not only summarize what is now known about the mGluRs, but also illuminate the areas in which there is the greatest need for focused research. Glutamic acid is an amino acid that has long been known to play several important metabolic roles in central and peripheral tissues and to be a component of several naturally occurring molecules. The first evidence that glutamate mayaIso serve as a neurotransmitter in the central nervous system (CNS) came in the late 1950s and early 1960s when glutamate and other acidic amino acids were found to induce behavioral convulsions when topically applied to the cortex and to excite a wide variety of central neurons.These findings spurred a massive research effort that quickly established glutamate as the pri- mary excitatory neurotransmitter in the vertebrate CNS. One of the most striking characteristics of glutamate that was quickly recognized was its ubiquitous role in serving as the neurotransmitter at the vast majority of excitatory synapses in the brain. It is now clear that most central neuronal circuits involve glutamatergic neurotransmission at some level.